In the early 2020s, interest in GLP 1 weight loss drugs exploded, said CNN. Now, a new buzzword is taking over: peptides. Once a niche interest among powerlifters and bodybuilders, the injectable substances Psychological and behavioral effects of GLP 1 and GIP agonists in weight loss: a comprehensive review Journal of Diabetes & Metabolic Disorders Springer Nature Link Beyond Weight Loss: ED Implications of the GLP 1 Era EMOttawa Blog Glucagon Like Peptide 1 Receptor Agonists and Dual Glucose Dependent Insulinotropic Polypeptide Glucagon Like Peptide 1 Receptor Agonists in the Treatment of Obesity Metabolic Syndrome, Prediabetes Diabetes and Non Alcoholic Fatty Liver DiseaseCurrent Frontiers Mechanisms of action and therapeutic applications of GLP 1 and dual GIP GLP 1 receptor agonists Key Findings: Duration Reduction: The study found that GLP 1 therapy significantly shortens the duration of BoNT A effects: In chronic migraine treatment, the mean duration dropped from 14.0 weeks to between 11.8